{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:27:02Z","timestamp":1787023622300,"version":"build-2736575974"},"reference-count":62,"publisher":"Impact Journals, LLC","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,4,25]]},"DOI":"10.18632\/oncotarget.15324","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T14:17:50Z","timestamp":1487168270000},"page":"28510-28525","source":"Crossref","is-referenced-by-count":71,"title":["Itraconazole exerts its anti-melanoma effect by suppressing Hedgehog, Wnt, and PI3K\/mTOR signaling pathways"],"prefix":"10.18632","volume":"8","author":[{"given":"Guanzhao","family":"Liang","sequence":"first","affiliation":[{"name":"Department of Mycology, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Mycology, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Mycology, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongnian","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Mycology, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Mei","sequence":"additional","affiliation":[{"name":"Department of Mycology, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Mycology, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China"},{"name":"Georgetown University Medical Center, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weida","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Mycology, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,2,14]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMra041245","article-title":"Management of cutaneous melanoma","volume":"351","author":"Sober","year":"2004","journal-title":"N Engl J Med"},{"key":"2","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1073\/pnas.0811902106","article-title":"Activated Wnt\/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model","volume":"106","author":"Moon","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Ewing","year":"2002","journal-title":"Nature"},{"key":"4","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The Genetic Evolution of Melanoma from Precursor Lesions","volume":"373","author":"Robson","year":"2015","journal-title":"N Engl J Med"},{"key":"5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ccr.2012.12.011","article-title":"Smoothing out drug resistance","volume":"23","author":"Toftgard","year":"2013","journal-title":"Cancer Cell"},{"key":"6","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1073\/pnas.0700776104","article-title":"Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK\/AKT pathways","volume":"104","author":"Ruiz","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7","first-page":"a3","article-title":"Wnt\/beta-catenin signaling and AXIN1 regulate apoptosis triggered by inhibition of the mutant kinase BRAFV600E in human melanoma","volume":"5","author":"Chien","year":"2012","journal-title":"Sci Signal"},{"key":"8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1021\/cb600362d","article-title":"Inhibition of angiogenesis by the antifungal drug itraconazole","volume":"2","author":"Liu","year":"2007","journal-title":"Acs Chem Biol"},{"key":"9","doi-asserted-by":"crossref","first-page":"6764","DOI":"10.1158\/0008-5472.CAN-11-0691","article-title":"Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer","volume":"71","author":"Rudin","year":"2011","journal-title":"Cancer Res"},{"key":"10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ccr.2010.02.027","article-title":"Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth","volume":"17","author":"Epstein","year":"2010","journal-title":"Cancer Cell"},{"key":"11","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1200\/JCO.2013.49.9525","article-title":"Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma","volume":"32","author":"Tang","year":"2014","journal-title":"J Clin Oncol"},{"key":"12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1634\/theoncologist.2012-314","article-title":"Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer","volume":"18","author":"Rudek","year":"2013","journal-title":"Oncologist"},{"key":"13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/JTO.0b013e31828c3950","article-title":"Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non-small-cell lung cancer","volume":"8","author":"Liu","year":"2013","journal-title":"J Thorac Oncol"},{"key":"14","first-page":"3839","article-title":"Impact of itraconazole on the survival of heavily pre-treated patients with triple-negative breast cancer","volume":"34","author":"Inoue","year":"2014","journal-title":"Anticancer Res"},{"key":"15","first-page":"2481","article-title":"Impact of combination chemotherapy with itraconazole on survival of patients with refractory ovarian cancer","volume":"34","author":"Inoue","year":"2014","journal-title":"Anticancer Res"},{"key":"16","doi-asserted-by":"crossref","first-page":"E7276","DOI":"10.1073\/pnas.1512867112","article-title":"Antifungal drug itraconazole targets VDAC1 to modulate the AMPK\/mTOR signaling axis in endothelial cells","volume":"112","author":"Zhao","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJMra052166","article-title":"Melanoma","volume":"355","author":"Mihm","year":"2006","journal-title":"N Engl J Med"},{"key":"18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrc2389","article-title":"Wnt signalling and its impact on development and cancer","volume":"8","author":"Birchmeier","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"19","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/gb-2004-5-7-234","article-title":"The Frizzled family: receptors for multiple signal transduction pathways","volume":"5","author":"Klein","year":"2004","journal-title":"Genome Biol"},{"key":"20","first-page":"632","article-title":"International Union of Basic and Clinical Pharmacology. LXXX. The class Frizzled receptors","volume":"62","author":"Schulte","year":"2010","journal-title":"Phamacol Rev"},{"key":"21","first-page":"279","article-title":"International Union of Pharmacology. XLVI. G protein-coupled receptor list","volume":"57","author":"Harmar","year":"2005","journal-title":"Phamacol Rev"},{"key":"22","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1158\/0008-5472.CAN-10-0646","article-title":"RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models","volume":"70","author":"Heimbrook","year":"2010","journal-title":"Cancer Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13000-015-0431-9","article-title":"A p16-Ki-67-HMB45 immunohistochemistry scoring system as an ancillary diagnostic tool in the diagnosis of melanoma","volume":"10","author":"Marcorelles","year":"2015","journal-title":"Diagn Pathol"},{"key":"24","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sabatini","year":"2005","journal-title":"Science"},{"key":"25","doi-asserted-by":"crossref","first-page":"40406","DOI":"10.1074\/jbc.M508361200","article-title":"mTOR.RICTOR is the Ser473 kinase for Akt\/protein kinase B in 3T3-L1 adipocytes","volume":"280","author":"Mueckler","year":"2005","journal-title":"J Biol Chem"},{"key":"26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Forman","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"27","first-page":"1425","article-title":"Targeting hedgehog signaling in cancer: research and clinical developments","volume":"6","author":"Gu","year":"2013","journal-title":"Onco Targets Ther"},{"key":"28","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1158\/1078-0432.CCR-09-2570","article-title":"The role of the hedgehog signaling pathway in the development of basal cell carcinoma and opportunities for treatment","volume":"16","author":"Low","year":"2010","journal-title":"Clin Cancer Res"},{"key":"29","first-page":"181","article-title":"Hedgehog beyond medulloblastoma and basal cell carcinoma","volume":"1805","author":"Toftgard","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"30","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1101\/gad.1437206","article-title":"Malignant melanoma: genetics and therapeutics in the genomic era","volume":"20","author":"Fisher","year":"2006","journal-title":"Genes Dev"},{"key":"31","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/73417","article-title":"Basal cell carcinomas in mice overexpressing Gli2 in skin","volume":"24","author":"Dlugosz","year":"2000","journal-title":"Nat Genet"},{"key":"32","doi-asserted-by":"crossref","first-page":"22888","DOI":"10.1074\/jbc.M109.021949","article-title":"The hedgehog pathway transcription factor GLI1 promotes malignant behavior of cancer cells by up-regulating osteopontin","volume":"284","author":"Shevde","year":"2009","journal-title":"J Biol Chem"},{"key":"33","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/jnci\/djq257","article-title":"GLI2-mediated melanoma invasion and metastasis","volume":"102","author":"Verrecchia","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"34","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cub.2007.01.062","article-title":"Inhibitory Gli3 activity negatively regulates Wnt\/beta-catenin signaling","volume":"17","author":"Briscoe","year":"2007","journal-title":"Curr Biol"},{"key":"35","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature12167","article-title":"Structure of the human smoothened receptor bound to an antitumour agent","volume":"497","author":"Stevens","year":"2013","journal-title":"Nature"},{"key":"36","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.2174\/138945010792006780","article-title":"A Wnt-ow of opportunity: targeting the Wnt\/beta-catenin pathway in breast cancer","volume":"11","author":"Goss","year":"2010","journal-title":"Curr Drug Targets"},{"key":"37","doi-asserted-by":"crossref","first-page":"17135","DOI":"10.1073\/pnas.1104182108","article-title":"Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt\/beta-catenin signaling","volume":"108","author":"Warmuth","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc3419","article-title":"WNT signalling pathways as therapeutic targets in cancer","volume":"13","author":"Moon","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1083\/jcb.152.1.87","article-title":"Wnt-1 signaling inhibits apoptosis by activating beta-catenin\/T cell factor-mediated transcription","volume":"152","author":"Wang","year":"2001","journal-title":"J Cell Biol"},{"key":"40","doi-asserted-by":"crossref","first-page":"621","DOI":"10.4161\/cbt.309","article-title":"beta-Catenin signaling: therapeutic strategies in oncology","volume":"1","author":"Thompson","year":"2002","journal-title":"Cancer Biol Ther"},{"key":"41","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/1471-2407-6-221","article-title":"Identification of genes regulated by Wnt\/beta-catenin pathway and involved in apoptosis via microarray analysis","volume":"6","author":"Xu","year":"2006","journal-title":"BMC Cancer"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Polakis. Wnt signaling in cancer. Cold Spring Harb Perspect Biol. 2012; p. 4.","DOI":"10.1101\/cshperspect.a008052"},{"key":"43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.5306\/wjco.v2.i8.311","article-title":"Dickkopfs and Wnt\/beta-catenin signalling in liver cancer","volume":"2","author":"Luk","year":"2011","journal-title":"World J Clin Oncol"},{"key":"44","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1093\/carcin\/bgq169","article-title":"Specific targeting of Wnt\/beta-catenin signaling in human melanoma cells by a dietary triterpene lupeol","volume":"31","author":"Mukhtar","year":"2010","journal-title":"Carcinogenesis"},{"key":"45","first-page":"e11","article-title":"A Wnt-er migration: the confusing role of beta-catenin in melanoma metastasis","volume":"6","author":"Weeraratna","year":"2013","journal-title":"Sci Signal"},{"key":"46","first-page":"a3","article-title":"Wnt\/beta-catenin signaling and AXIN1 regulate apoptosis triggered by inhibition of the mutant kinase BRAFV600E in human melanoma","volume":"5","author":"Chien","year":"2012","journal-title":"Sci Signal"},{"key":"47","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrd4204","article-title":"PI3K and cancer: lessons, challenges and opportunities","volume":"13","author":"Rommel","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrm3290","article-title":"PI3K signalling: the path to discovery and understanding","volume":"13","author":"Hawkins","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"49","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/PPO.0b013e31824d448c","article-title":"The role of the PI3K-AKT pathway in melanoma","volume":"18","author":"Davies","year":"2012","journal-title":"CANCER J"},{"key":"50","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4103\/1008-682X.122876","article-title":"PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance","volume":"16","author":"Hsieh","year":"2014","journal-title":"Aian J Androl"},{"key":"51","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/01.RES.0000253094.03023.3f","article-title":"Hypoxia-induced endothelial proliferation requires both mTORC1 and mTORC2","volume":"100","author":"Humar","year":"2007","journal-title":"Circ Res"},{"key":"52","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/0092-8674(92)90643-Q","article-title":"Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases","volume":"69","author":"Blenis","year":"1992","journal-title":"Cell"},{"key":"53","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.1380182","article-title":"Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase","volume":"257","author":"Bierer","year":"1992","journal-title":"Science"},{"key":"54","doi-asserted-by":"crossref","first-page":"18531","DOI":"10.1074\/jbc.270.31.18531","article-title":"Control of PHAS-I by insulin in 3T3-L1 adipocytes. Synthesis, degradation, and phosphorylation by a rapamycin-sensitive and mitogen-activated protein kinase-independent pathway","volume":"270","author":"Lawrence","year":"1995","journal-title":"J Biol Chem"},{"key":"55","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1073\/pnas.93.9.4076","article-title":"4E-BP1 phosphorylation is mediated by the FRAP-p70s6k pathway and is independent of mitogen-activated protein kinase","volume":"93","author":"Thomas","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"56","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.devcel.2007.03.020","article-title":"The two TORCs and Akt","volume":"12","author":"Hay","year":"2007","journal-title":"Dev Cell"},{"key":"57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2013.06.017","article-title":"mTOR kinase inhibitors as potential cancer therapeutic drugs","volume":"340","author":"Sun","year":"2013","journal-title":"Cancer Lett"},{"key":"58","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1517\/14728222.2012.691472","article-title":"Insights into melanoma: targeting the mTOR pathway for therapeutics","volume":"16","author":"Lopes","year":"2012","journal-title":"Expert Opin Ther Targets"},{"key":"59","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.biopha.2011.11.004","article-title":"Itraconazole inhibits HMEC-1 angiogenesis","volume":"66","author":"Balzan","year":"2012","journal-title":"Biomed Pharmacother"},{"key":"60","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2169\/internalmedicine.38.829","article-title":"Successful treatment of cerebral aspergillosis with a high oral dose of itraconazole after excisional surgery","volume":"38","author":"Uede","year":"1999","journal-title":"Intern Med"},{"key":"61","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/clinids\/23.5.1196","article-title":"High-dose itraconazole for the treatment of cerebral aspergillosis","volume":"23","author":"Meis","year":"1996","journal-title":"Clin Infect Dis"},{"key":"62","doi-asserted-by":"crossref","unstructured":"Chen, Sun, Feng, Ran, Lama, Ran. Efficacy and safety of itraconazole use in infants. World J Pediatr. 2016.","DOI":"10.1007\/s12519-016-0034-x"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15324","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T14:33:03Z","timestamp":1589121183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,14]]},"references-count":62,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2017,4,25]]}},"alternative-id":["15324","28212537"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.15324","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,14]]}}}